Mice lacking the transcriptional coactivator PGC-1α exhibit alterations in inhibitory synaptic transmission in the motor cortex

Neuroscience

Volumn 271, Issue , 2014, Pages 137-148

  Dougherty, S E ^a   Bartley, A F ^b   Lucas, E K ^a   Hablitz, J J ^b   Dobrunz, L E ^b   Cowell, R M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Inhibitory neurotransmission; Interneuron; Motor cortex; Parvalbumin; Peroxisome proliferator activated receptor gamma coactivator 1

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; 4 AMINOBUTYRIC ACID; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; PARVALBUMIN; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

4 AMINOBUTYRIC ACID RELEASE; AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EXCITABILITY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; FREQUENCY MODULATION; GAMMA RHYTHM; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; MOTOR CORTEX; MOTOR DYSFUNCTION; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NERVE CELL STIMULATION; NONHUMAN; PGC 1ALPHA GENE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; ACTION POTENTIAL; ANIMAL; C57BL MOUSE; DEFICIENCY; ELECTROSTIMULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; PATCH CLAMP TECHNIQUE; PATHOLOGY; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ACTION POTENTIALS; ANIMALS; ELECTRIC STIMULATION; GAMMA-AMINOBUTYRIC ACID; GREEN FLUORESCENT PROTEINS; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR CORTEX; NEURAL INHIBITION; NEURONS; PARVALBUMINS; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTORS;

EID: 84900523829     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.023     Document Type: Article

References (49)

1. Alberi L., Lintas A., Kretz R., Schwaller B., Villa A.E. The calcium-binding protein parvalbumin modulates the firing 1 properties of the reticular thalamic nucleus bursting neurons. J Neurophysiol 2013, 109(11):2827-2841.
2. Bartley A.F., Huang Z.J., Huber K.M., Gibson J.R. Differential activity-dependent, homeostatic plasticity of two neocortical inhibitory circuits. J Neurophysiol 2008, 100(4):1983-1994.
3. Bartos M., Vida I., Frotscher M., Meyer A., Monyer H., Geiger J.R., Jonas P. Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks. Proc Natl Acad Sci U S A 2002, 99(20):13222-13227.
4. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007, 8(1):45-56.
5. Caillard O., Moreno H., Schwaller B., Llano I., Celio M.R., Marty A. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci U S A 2000, 97(24):13372-13377.
6. Chattopadhyaya B., Di Cristo G., Higashiyama H., Knott G.W., Kuhlman S.J., Welker E., Huang Z.J. Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period. J Neurosci 2004, 24(43):9598-9611.
7. Chaturvedi R.K., Calingasan N.Y., Yang L., Hennessey T., Johri A., Beal M.F. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation. Hum Mol Genet 2010, 19(16):3190-3205.
8. Christoforou A., Le Hellard S., Thomson P.A., Morris S.W., Tenesa A., Pickard B.S., Wray N.R., Muir W.J., Blackwood D.H., Porteous D.J., Evans K.L. Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. Mol Psychiatry 2007, 12(11):1011-1025.
9. Cowell R.M., Blake K.R., Russell J.W. Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J Comp Neurol 2007, 502(1):1-18.
10. Cowell R.M., Talati P., Blake K.R., Meador-Woodruff J.H., Russell J.W. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun 2009, 379(2):578-582.
11. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127(1):59-69.
12. Dobrunz L.E. Release probability is regulated by the size of the readily releasable vesicle pool at excitatory synapses in hippocampus. Int J Dev Neurosci 2002, 20(3-5):225-236.
13. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18(6):995-1008.
14. Dobrunz L.E., Huang E.P., Stevens C.F. Very short-term plasticity in hippocampal synapses. Proc Natl Acad Sci U S A 1997, 94(26):14843-14847.
15. Farre-Castany M.A., Schwaller B., Gregory P., Barski J., Mariethoz C., Eriksson J.L., Tetko I.V., Wolfer D., Celio M.R., Schmutz I., Albrecht U., Villa A.E. Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 2007, 178(2):250-261.
16. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006, 116(3):615-622.
17. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 2003, 26(9):489-495.
18. Freund T.F., Katona I. Perisomatic inhibition. Neuron 2007, 56(1):33-42.
19. Hettema J.M., Webb B.T., Guo A.Y., Zhao Z., Maher B.S., Chen X., An S.S., Sun C., Aggen S.H., Kendler K.S., Kuo P.H., Otowa T., Flint J., van den Oord E.J. Prioritization and association analysis of murine-derived candidate genes in anxiety-spectrum disorders. Biol Psychiatry 2011, 70(9):888-896.
20. Jiang Z., Cowell R.M., Nakazawa K. Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia. Front Behav Neurosci 2013, 7:116.
21. Jiang Z., Rompala G.R., Zhang S., Cowell R.M., Nakazawa K. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol Psychiatry 2013, 73(10):1024-1034.
22. Kawaguchi Y. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 1993, 13(11):4908-4923.
23. Kawaguchi Y., Kondo S. Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 2002, 31(3-5):277-287.
24. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68(3):557-569.
25. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jager S., Vianna C.R., Reznick R.M., Cui L., Manieri M., Donovan M.X., Wu Z., Cooper M.P., Fan M.C., Rohas L.M., Zavacki A.M., Cinti S., Shulman G.I., Lowell B.B., Krainc D., Spiegelman B.M. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119(1):121-135.
26. Lucas E.K., Markwardt S.J., Gupta S., Meador-Woodruff J.H., Lin J.D., Overstreet-Wadiche L., Cowell R.M. Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha. J Neurosci 2010, 30(21):7227-7235.
27. Lucas E.K., Dougherty S.E., McMeekin L.J., Trinh A.T., Reid C.S., Cowell R.M. Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1alpha. PLoS One 2012, 7(8):e42878.
28. Ma D., Li S., Lucas E.K., Cowell R.M., Lin J.D. Neuronal inactivation of peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) protects mice from diet-induced obesity and leads to degenerative lesions. J Biol Chem 2010, 285(50):39087-39095.
29. Magee J.C. Dendritic integration of excitatory synaptic input. Nat Rev Neurosci 2000, 1(3):181-190.
30. Pozzo-Miller L.D., Gottschalk W., Zhang L., McDermott K., Du J., Gopalakrishnan R., Oho C., Sheng Z.H., Lu B. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 1999, 19(12):4972-4983.
31. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92(6):829-839.
32. Qin W., Haroutunian V., Katsel P., Cardozo C.P., Ho L., Buxbaum J.D., Pasinetti G.M. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 2009, 66(3):352-361.
33. Ramirez D.M., Kavalali E.T. Differential regulation of spontaneous and evoked neurotransmitter release at central synapses. Curr Opin Neurobiol 2011, 21(2):275-282.
34. Rotaru D.C., Yoshino H., Lewis D.A., Ermentrout G.B., Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci 2011, 31(1):142-156.
35. Schikorski T., Stevens C.F. Morphological correlates of functionally defined synaptic vesicle populations. Nat Neurosci 2001, 4(4):391-395.
36. Schwaller B., Dick J., Dhoot G., Carroll S., Vrbova G., Nicotera P., Pette D., Wyss A., Bluethmann H., Hunziker W., Celio M.R. Prolonged contraction-relaxation cycle of fast-twitch muscles in parvalbumin knockout mice. Am J Physiol 1999, 276(2 Pt 1):C395-C403.
37. Sheng B., Wang X., Su B., Lee H.G., Casadesus G., Perry G., Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 2012, 120(3):419-429.
38. Sohal V.S. Insights into cortical oscillations arising from optogenetic studies. Biol Psychiatry 2012, 71(12):1039-1045.
39. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459(7247):698-702.
40. Speed H.E., Dobrunz L.E. Developmental changes in short-term facilitation are opposite at temporoammonic synapses compared to Schaffer collateral synapses onto CA1 pyramidal cells. Hippocampus 2009, 19(2):187-204.
41. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127(2):397-408.
42. Taherzadeh-Fard E., Saft C., Andrich J., Wieczorek S., Arning L. PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 2009, 4:10.
43. Tepper J.M., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 2004, 14(6):685-692.
44. Traub R.D., Whittington M.A., Colling S.B., Buzsaki G., Jefferys J.G. Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo. J Physiol 1996, 493(Pt 2):471-484.
45. Vreugdenhil M., Jefferys J.G., Celio M.R., Schwaller B. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol 2003, 89(3):1414-1422.
46. Walters B.J., Hallengren J.J., Theile C.S., Ploegh H.L., Wilson S.M., Dobrunz L.E. A catalytic independent function of the deubiquitinating enzyme USP14 regulates hippocampal synaptic short-term plasticity and vesicle number. J Physiol 2014, 592(Pt 4):571-586.
47. Wang X.J., Buzsaki G. Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model. J Neurosci 1996, 16(20):6402-6413.
48. Witte M.E., Nijland P.G., Drexhage J.A., Gerritsen W., Geerts D., van Het Hof B., Reijerkerk A., de Vries H.E., van der Valk P., van Horssen J. Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol 2013, 125(2):231-243.
49. Zheng B., Liao Z., Locascio J.J., Lesniak K.A., Roderick S.S., Watt M.L., Eklund A.C., Zhang-James Y., Kim P.D., Hauser M.A., Grunblatt E., Moran L.B., Mandel S.A., Riederer P., Miller R.M., Federoff H.J., Wullner U., Papapetropoulos S., Youdim M.B., Cantuti-Castelvetri I., Young A.B., Vance J.M., Davis R.L., Hedreen J.C., Adler C.H., Beach T.G., Graeber M.B., Middleton F.A., Rochet J.C., Scherzer C.R. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2010, 2(52):52ra73.